on October 30, 2026
The brain and the language of Omega-3s
Omega-3 polyunsaturated fatty acids represent one of the most interesting components of the relationship between diet and brain health.
They are not simply nutrients used as an energy source. Long-chain Omega-3s, especially docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), enter the structure of cell membranes and contribute to determining their fluidity, organization, and communication capacity.
DHA is particularly abundant in the nervous system and the retina. Its presence in neuronal membranes contributes to the physical properties of the membrane and the functioning of receptors, channels, and proteins involved in signal transmission.
EPA, on the other hand, is particularly important in the regulation of inflammatory processes and the production of lipid mediators. DHA and EPA can indeed be converted into bioactive molecules involved in the resolution of inflammation, including the so-called specialized pro-resolving mediators.
Their action must therefore be interpreted within a broader view: cell membranes, lipid metabolism, the cardiovascular system, immunity, and neuronal communication are biologically interconnected systems.
ALA, EPA, and DHA: they are not all the same
Omega-3s include several molecules.
Alpha-linolenic acid (ALA) is an essential fatty acid that must be introduced through diet. It is found mainly in plant foods such as flaxseeds, chia seeds, walnuts, and some vegetable oils.
EPA and DHA, on the other hand, are long-chain Omega-3s found mainly in fatty fish and foods of marine origin.
The human body can convert ALA into EPA and DHA, but this conversion is limited. For this reason, when the nutritional goal is to ensure an adequate supply of EPA and DHA, their direct presence in the diet takes on particular importance.
It is therefore reductive to speak generically of “Omega-3s”: origin, composition, quantity, bioavailability, and the ratio between the different forms must be considered separately.
A neuronal membrane rich in DHA
The brain is particularly sensitive to the lipid composition of membranes.
DHA contributes to the organization of neuronal membranes and synapses, that is, the structures through which nerve cells communicate with each other. A correct lipid composition can influence the localization and activity of receptors, membrane proteins, and signal transduction systems.
Experimental studies have also shown that the availability of Omega-3s can influence processes such as synaptic plasticity, neuroinflammation, oxidative stress, and neuronal survival.
This helps explain why the relationship between Omega-3s and the brain cannot be reduced to the simple question: “Do Omega-3s improve memory?”
The biologically more interesting question is rather: at what stage of life, in what metabolic context, and in which individuals can an adequate Omega-3 status contribute to maintaining an environment favorable to brain function?
Omega-3s and the brain from middle age onward
One of the most interesting aspects of research concerns the fact that the possible effects of Omega-3s do not seem to be exclusively a matter of old age.
A study conducted within the Framingham Heart Study analyzed 2,183 people without dementia or stroke, with an average age of around 46 years. Researchers measured EPA and DHA in red blood cells and correlated them with brain MRI images and neuropsychological tests.
Participants with higher Omega-3 levels had a larger hippocampal volume and better performance on an abstract reasoning test. Higher Omega-3 levels were also associated with a lower presence of white matter hyperintensities, an indicator correlated with small vessel brain health.
The hippocampus is a fundamental structure for memory and learning. The finding is therefore biologically interesting, especially because brain alterations associated with aging can begin many years before the appearance of true cognitive impairment.
This demonstrates an association between Omega-3 levels and some indicators of brain health, implicated in the biological mechanisms with an increase in hippocampal volume.
The role of APOE: the response is not necessarily the same for everyone
Brain research is also highlighting how important individual variability is.
In the same study, the associations between Omega-3s, hippocampal volume, and white matter differed depending on the APOE status, a gene involved in lipid metabolism and transport and also known for its relationship with Alzheimer's disease risk.
This result is particularly interesting from the perspective of personalized nutrition.
The same amount of a nutrient may not necessarily produce the same biological response in metabolically different people. Genetics, age, inflammatory status, lipid metabolism, overall diet, and cardiovascular conditions can modify the relationship between nutrient and organism.
It is one of the reasons why a modern nutritional strategy should not be limited to generically prescribing “more Omega-3s,” but should consider the biological context in which these nutrients are introduced.
Neuroinflammation: when lipid metabolism becomes a signal
One of the most interesting hypotheses concerns the relationship between Omega-3s and inflammation.
EPA and DHA can be incorporated into cell membranes and subsequently used as substrates for the production of lipid mediators. Some of these participate in the regulation and resolution of the inflammatory response.
The concept of “resolution” is important.
Inflammation is not necessarily a process to be eliminated. It is a necessary biological response. The problem arises when the inflammatory response is not adequately resolved and tends to become persistent.
In the nervous system, the balance between pro-inflammatory and pro-resolving signals also involves microglia, the brain's resident immune cells.
In this scenario, Omega-3s can be considered signaling molecules, in addition to structural components of membranes.
It is a perspective particularly consistent with a biomolecular view of diet: food not only provides calories and micronutrients, but also molecules capable of interacting with cellular and metabolic processes.
Omega-3s, attention, and cognitive functions: what does clinical research say?
When moving from observational studies to intervention studies, the picture becomes more complex.
A meta-analysis published in 2025 collected 58 randomized controlled trials to evaluate the dose-response relationship between Omega-3 supplementation and cognitive function in adults.
The analysis highlighted improvements in several functions, including attention, perceptual speed, language, primary memory, visuospatial skills, and overall cognitive ability. The same researchers emphasize the need for better-designed randomized studies with longer follow-up.
This is a key point.
Having higher levels of Omega-3 in the blood is associated with better brain health in several studies; this does not automatically mean that supplementation produces cognitive improvement in every individual.
The difference between biological association and clinical benefit must be maintained.
Why the timing of the intervention may be important
One possible explanation for the differences observed between epidemiological studies and supplementation studies concerns the timing of the intervention.
The brain does not suddenly go from a healthy state to a neurodegenerative condition. The biological processes preceding cognitive decline can develop over many years.
If vascular, neuroinflammatory, metabolic, and synaptic alterations are already advanced, correcting a single nutritional element later may not be sufficient.
This suggests an interesting perspective: brain nutrition may be more effective as a strategy for maintaining homeostasis than as a late intervention for damage that has already become established.
It is also an important conceptual difference when talking about longevity.
The brain is not separate from the heart
Brain health also depends on cardiovascular health.
Small brain vessels are extremely sensitive to blood pressure, metabolic alterations, diabetes, dyslipidemia, and atherosclerosis.
Omega-3s can act on some of these factors.
A meta-analysis of 71 randomized trials, including 4,973 participants, evaluated the dose-response relationship between EPA+DHA and blood pressure. An intake of approximately 2-3 g per day was associated with a greater average reduction in blood pressure, equal to approximately 2.6 mmHg for systolic pressure and 1.6-1.8 mmHg for diastolic. The effects appeared more pronounced in people with hypertension, hyperlipidemia, and in older age groups.
It is therefore not exclusively a “brain” effect.
Better control of cardiovascular factors can indirectly contribute to brain protection, because the heart, endothelium, and vascular nervous system share many of the same metabolic and inflammatory pathways.
Omega-3 and autoimmune diseases: an interesting signal
Interest in Omega-3s also concerns immune regulation.
In the large VITAL trial, supplementation with 1,000 mg per day of Omega-3 was evaluated in relation to the incidence of autoimmune diseases. The follow-up highlighted, approximately seven years after the start of the study, 234 cases of autoimmune disease in the Omega-3 group versus 280 in the placebo group, with HR 0.83 (95% CI 0.70-0.99).
The result is interesting because it suggests a possible persistent effect after the treatment phase.
The data concerns the reduction in the incidence of new autoimmune diseases in a specific studied population, not the treatment of an already diagnosed autoimmune condition.
How much Omega-3 to take?
The requirement cannot be reduced to a single dose valid for everyone.
For the general population, the nutritional reference levels for EPA+DHA are in the range of a few hundred milligrams per day, while significantly higher quantities have been used in clinical trials for specific objectives.
This means that the nutritional dose and the dose used in a clinical study are not necessarily the same thing.
Furthermore, high-dose supplementation should not be undertaken independently. The choice must take into account diet, blood levels, triglycerides, medications taken, and the individual cardiovascular profile.
Particular attention is needed in subjects taking medications that interfere with coagulation or in the presence of specific cardiovascular conditions.
Fish, diet, and supplementation
The nutritional approach should start with diet.
Blue fish and fatty fish represent important sources of EPA and DHA. Plant-based foods, on the other hand, provide mainly ALA.
Supplementation can become a possibility when diet does not allow for an adequate intake or when specific nutritional needs exist.
In this case, it should not be sufficient to read the word “Omega-3” on the label.
It is necessary to check:
- actual quantity of EPA;
- actual quantity of DHA;
- total quantity of oil, which does not necessarily coincide with the quantity of EPA+DHA;
- chemical form and bioavailability;
- purity and oxidative stability;
- controls on the presence of contaminants;
- quality of the raw material;
- any independent analytical certifications.
The quality of the oil is also important because polyunsaturated fatty acids are sensitive to oxidation.
A Biomolecular Nutrition Perspective
Omega-3s clearly demonstrate how diet can be understood as a true signaling medicine, without turning food into medicine.
EPA and DHA do not act through a single mechanism. They interact with membranes, receptors, lipid mediators, metabolism, the immune system, and cell communication.
Their biological significance therefore emerges from the interaction between multiple systems.
For brain health, this approach is particularly important: memory, attention, and cognitive abilities do not depend on a single food or a single supplement, but on the balance between nutrition, energy metabolism, vascular health, physical activity, sleep, stress, microbiota, and inflammation.
The gut microbiota can also be included in this model, because fatty acid metabolism, intestinal permeability, immunity, and neuroendocrine signals contribute to communication along the gut-brain axis.
The question therefore should not only be “How much Omega-3 should I take?”, but rather:
“What nutritional approach can support the maintenance of brain homeostasis in my specific biological context?”
This is the direction in which personalized nutrition is moving: not one nutrient for everyone, but a strategy built on the relationship between the person, diet, and biological response.
Key takeaway
Omega-3s, and DHA and EPA in particular, are important components of brain biology.
Available evidence shows associations between higher Omega-3 levels and some favorable indicators of brain structure and function as early as middle age. Clinical studies on supplementation suggest possible cognitive benefits, but do not justify considering Omega-3s a therapy or a guarantee of preventing cognitive decline.
The most solid perspective is therefore to consider them within a comprehensive model of brain health, in which diet, metabolism, the cardiovascular system, inflammation, microbiota, physical activity, and lifestyle together contribute to the body's ability to maintain its homeostasis.
PLEASE NOTE
The information provided is for informational and educational purposes only and does not constitute medical advice, nor does it replace a medical evaluation, diagnosis, or prescription of therapy. Dietary supplements are not medicines and should not be considered tools to prevent, diagnose, treat, or alleviate diseases. The decision to take a supplement should be evaluated in relation to individual characteristics, diet, health conditions, and any medications being taken.
Bibliographic references
- Zhang X, Ritonja JA, Zhou N, Chen BE, Li X. Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2022;11(11).
- Satizabal CL, Himali JJ, Beiser AS, et al. Association of Red Blood Cell Omega-3 Fatty Acids With MRI Markers and Cognitive Function in Midlife: The Framingham Heart Study. Neurology. 2022;99(23).
- Shahinfar H, Yazdian Z, Asgari Avini N, et al. A systematic review and dose response meta analysis of Omega 3 supplementation on cognitive function. Sci Rep. 2025;15(1):30610.
- Costenbader KH, Cook NR, Lee IM, et al. Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2024;76(6):973-983.
PRODUCT_ARTICLE
